Blog

(Source:Georgetown University Medical Center) Originally published Sep 27, 2022, Medical Life Sciences Giving immunotherapy before targeted therapy improves survival in…

by Alicia Rowell, Vice President Saturday, June 4 was a special evening. In Chicago that week many of the nation’s…

From the Desk of Samantha Guild Leaves are falling, pumpkins are out, football is on TV, and the kids are…

By Mara Klecker Ann Garst Taylor, AIM at Melanoma’s new Director of Community Engagement, has nearly 30 years of volunteer…

by Mara Klecker Michelle Bessett has always loved working with and helping other people. As AIM at Melanoma’s new Director…

(NEWS PROVIDED BY  Bristol Myers Squibb, September 16, 2022, ) Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the…

When faced with a cancer diagnosis, some patients rely on their spirituality to cope and find meaning behind the experience.…

(NEWS PROVIDED BY  Pharmaphorum, September 11, 2022, Phil Taylor) A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has…

(NEWS PROVIDED BY Regeneron Pharmaceuticals, Inc. Sep 12, 2022, 02:30 ET) Positive clinical data presented in a mini-oral session at ESMO…

Neoadjuvant IO Boosts High-Risk Melanoma EFS Results from the phase 2 SWOG S1801 study show that for patients given pembrolizumab…